Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Oklahoma: The Complete Guide for Women, Families, and Survivors

If you are reading this in Oklahoma, you may be facing one of the most frightening medical and legal challenges of your life. Whether you underwent a post-mastectomy reconstruction at a major center like the OU Health Stephenson Cancer Center in Oklahoma City, a cosmetic augmentation in a private practice in Tulsa, or a revision procedure in Edmond, you likely trusted that the devices placed in your body were fully vetted for safety. For many women across Oklahoma, that trust has been shattered by the realization that acellular dermal matrix (ADM), surgical mesh, and bioabsorbable scaffolds were never specifically cleared or approved by the FDA for use in breast tissue.

We understand the isolation that comes with a diagnosis like Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) or the frustration of chronic infections and “Red Breast Syndrome” that won’t go away. At The Manginello Law Firm, PLLC, operating under the brand Attorney911, we have dedicated our practice to holding multi-billion-dollar medical device manufacturers accountable. Managing Partner Ralph Manginello, who has been licensed to practice for twenty-seven years, brings a high-level command of federal product liability law to every case we handle. Along with associate attorney Lupe Peña, our firm provides the technical and liturgical oversight necessary to challenge the corporate giants responsible for these defective products. If you are hurting, we are here to help you find answers and pursue justice. You can reach us 24/7 at 1-888-ATTY-911 for a completely confidential and free consultation.

This guide is designed to be the definitive resource for Oklahoma patients. We will break down the science of why these devices fail, the regulatory shortcuts that allowed them onto the market, and the specific legal framework that governs your rights in Oklahoma. Whether you are a cancer survivor, a prophylactic mastectomy patient, or a cosmetic surgery recipient, you deserve to know the truth about what is happening in your body and what the legal system can do to help you.

Understanding the Devices: ADM, Scaffolds, and Mesh in Oklahoma Breast Surgery

In the medical community serving Oklahoma City, Tulsa, and Norman, surgeons have increasingly turned to “internal bra” techniques to support implants and tissue expanders. These techniques rely on three categories of products that are now the focus of intense litigation and FDA scrutiny.

Acellular Dermal Matrix (ADM)

Acellular Dermal Matrix (ADM) is a biologic material derived from human cadaver skin or animal tissue (porcine or bovine). The manufacturing process involves decellularizing the tissue to leave behind a regenerative collagen scaffold. Common brands used in Oklahoma hospitals include AlloDerm (Allergan/AbbVie), FlexHD (MTF Biologics), and AlloMax (Becton Dickinson). While these products are often marketed as “natural,” they carry significant risks of endotoxin contamination and immunological rejection. We have seen cases where Oklahoma patients were never told these biologic grafts were being used off-label in their breast reconstruction.

Bioabsorbable and Resorbable Scaffolds

Unlike permanent mesh, bioabsorbable scaffolds are synthetic materials designed to be absorbed by the body over a period of 12 to 24 months. The most prominent example is GalaFLEX, made from poly-4-hydroxybutyrate (P4HB). Other products include Phasix and DuraSorb. These are often used in mastopexy (breast lift) or reconstruction to provide temporary support. However, as Ralph Manginello often points out to our clients, the hydrolysis kinetics of these materials can be unpredictable. If the scaffold degrades too quickly, the reconstruction fails; if it fails to resorbe, it becomes a permanent foreign body that triggers chronic pain and inflammation.

Synthetic Surgical Mesh

While less common in modern breast surgery than ADM, synthetic polypropylene mesh—originally designed for hernia repair—is sometimes used off-label in Oklahoma operating rooms. This material is notoriously prone to erosion and “shrinkage,” which can cause permanent disfigurement and neuropathic pain.

If you suspect one of these devices was used in your surgery, the first step is obtaining your operative reports. Oklahoma law gives you the absolute right to your medical records. Our firm, led by Ralph Manginello and Lupe Peña, can assist Oklahoma families in navigating the records request process to identify the lot numbers and Unique Device Identifiers (UDI) of the products implanted in your body. Call 1-888-ATTY-911 to discuss how we begin the investigation into your specific device history.

The Complication Spectrum: What Oklahoma Patients Need to Watch For

The injuries associated with defective breast mesh and ADM are not just “unfortunate side effects.” In many cases, they are the result of manufacturing defects or a failure to warn about known risks. For our clients in Oklahoma, these complications often fall into several critical categories.

BIA-ALCL: The Textured Implant Cancer

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a distinct T-cell lymphoma that develops in the scar tissue around an implant. It is not breast cancer; it is a cancer of the immune system. The World Health Organization has recognized this as a distinct malignancy since 2016. In Oklahoma, we closely monitor the pathology reports of our clients for CD30-positive and ALK-negative markers, which are the hallmarks of this disease. Lupe Peña, who conducts consultations in fluent Spanish, has seen how the language barrier can sometimes delay a patient’s understanding of this life-threatening diagnosis. If you have been diagnosed with BIA-ALCL in Oklahoma, the time to act is now.

BIA-SCC: An Emerging Threat

The FDA issued a safety communication in September 2022 regarding Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC). This epithelial tumor is found in the implant capsule and has a reported latency of 7 to 42 years post-implantation. For a woman in Oklahoma who had her original surgery decades ago, a new lump or sudden swelling could be a sign of this aggressive cancer.

Red Breast Syndrome and Endotoxin Science

Red Breast Syndrome (RBS) is a sterile, non-infectious inflammation that causes the breast skin to become bright red. Research, including the foundational work of Nguyen et al., suggests this is caused by bacterial endotoxins (lipopolysaccharides) retained on the acellular dermal matrix despite sterilization. Ralph Manginello and the team at Attorney911 use this scientific data to prove that the manufacturer’s processing methods were inadequate to protect Oklahoma patients.

Sepsis and Systemic Infection

When a cadaver-derived ADM or a synthetic mesh becomes colonized by bacteria, the result can be catastrophic. We represent Oklahoma families who have faced septic shock, multi-organ failure, and extended ICU stays because of infected surgical mesh. The “biofilm” that forms on these devices is often resistant to standard antibiotics, requiring multiple revision surgeries and, in many cases, total explantation (removal of the implant and the mesh).

If you are experiencing persistent redness, drainage, heat, or a palpable mass in your breast tissue, contact your medical provider in Oklahoma immediately. Once your health is stabilized, contact Ralph Manginello at 1-888-ATTY-911. We fight aggressively for every client we represent, drawing on our experience in high-profile institutional liability cases like Bermudez v. Pi Kappa Phi Fraternity to challenge the hospitals and manufacturers who put productivity over patient safety.

The FDA Regulatory Failure: The 510(k) “Predicate Creep”

Many Oklahoma patients are shocked to learn that the mesh or ADM used in their surgery was never “approved” by the FDA for use in the breast. Instead, these devices were “cleared” through the 510(k) pathway. Under 21 USC § 360c and 21 CFR Part 807, a manufacturer only has to show that their new device is “substantially equivalent” to a “predicate device” already on the market.

What is Predicate Creep?

Ralph Manginello often explains this to our clients as a regulatory game of “telephone.” A manufacturer might claim their new breast scaffold is substantially equivalent to a surgical suture, which was equivalent to a hernia mesh, which was equivalent to something else. This “predicate creep” allows materials that were never tested in breast tissue to enter Oklahoma operating rooms.

On November 9, 2023, the FDA issued a landmark letter to health care providers stating: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” This letter specifically named BD products like GalaFLEX and Phasix. This admission by the federal government is a powerful piece of evidence in your Oklahoma lawsuit. It proves that the “off-label” promotion of these devices occurred in a vacuum of safety data.

The Medtronic v. Lohr Precedent

Our legal strategy is built on the foundation of Medtronic v. Lohr (1996), where the Supreme Court held that 510(k) clearance does not preempt state-law negligence and product liability claims. Unlike Class III devices that go through the more rigorous Premarket Approval (PMA) process described in Riegel v. Medtronic (2008), 510(k) devices are not immune from lawsuits in Oklahoma courts. Ralph Manginello’s twenty-seven years of experience allow us to navigate these complex preemption defenses with surgical precision.

Why Your Oklahoma Location Matters: Legal Deadlines and Jurisdiction

In Oklahoma, the law provides a specific window of time to file a lawsuit, known as the statute of limitations. Generally, Oklahoma law requires that a personal injury or product liability lawsuit be filed within two years of the date of the injury or the date the injury was discovered.

The Discovery Rule in Oklahoma

Because mesh and ADM injuries often take years to manifest—BIA-ALCL, for instance, has an average onset of 7 to 10 years post-surgery—the “discovery rule” is critical. If you are in Oklahoma and only recently learned that your chronic infections or your cancer diagnosis were linked to a defective device, your two-year clock may only have started recently. However, evaluating these deadlines requires a detailed review of your medical history.

Federal Court and the Southern District of Texas Admission

While your case may arise in Oklahoma, these are often national “mass tort” litigations. Ralph Manginello is admitted to the United States District Court for the Southern District of Texas and has extensive experience in federal courts across the country. Whether your case is heard in an Oklahoma federal district court or centralized into a Multidistrict Litigation (MDL) like the Allergan BIOCELL MDL 2921 currently before Judge Brian R. Martinotti in the District of New Jersey, our firm has the reach to represent you.

No Fee Unless We Recover

We understand the financial toxicity of a cancer diagnosis or a failed reconstruction. For our Oklahoma clients, we work on a contingency-fee basis. This means you pay nothing upfront, and we only receive a fee if we successfully recover compensation for you. Case expenses may apply, but we handle the heavy lifting. You can call Lupe Peña or Ralph Manginello at 1-888-288-9911 anytime to discuss the specifics of your Oklahoma claim.

The Whistleblower: Dr. Hooman Noorchashm and Becton Dickinson

One of the most disturbing aspects of the GalaFLEX and Phasix litigation is the testimony of Dr. Hooman Noorchashm. A cardiothoracic surgeon and former Medical Director at Becton Dickinson (BD), Dr. Noorchashm was terminated in 2022 after he raised internal alarms about the safety of GalaFLEX in breast surgery.

Dr. Noorchashm has alleged that BD withheld data from the FDA regarding breast cancer recurrences in their clinical trials and engaged in aggressive off-label marketing to Oklahoma surgeons and others nationwide. He and other advocates have argued that the use of these “scaffolds” essentially turned Oklahoma women into human test subjects without their informed consent. At The Manginello Law Firm, PLLC, we incorporate this high-level whistleblower evidence into our litigation strategy to show that corporate greed, not medical necessity, led to your injury.

Damages: What Can Oklahoma Families Recover?

When we file a lawsuit for an Oklahoma patient, we are seeking “damages”—compensation for the myriad ways the defective device has harmed your life. These include:

• Medical Expenses: The cost of every revision surgery, the cost of specialized imaging (like a breast MRI to detect BIA-ALCL), and the cost of extended IV antibiotic therapy for Oklahoma patients who suffered sepsis.
• Lost Wages and Earning Capacity: Many Oklahoma women have missed months or even years of work while battling complications.
• Pain and Suffering: The physical agony of “Red Breast Syndrome,” capsular contracture, and the emotional trauma of a cancer diagnosis.
• Permanent Disfigurement: If a mesh infection caused you to lose your reconstruction and you are now “flat” on one or both sides, the law recognizes this as a permanent and life-altering loss.
• Loss of Consortium: Defective device injuries affect your marriage and your family life in Oklahoma. Spouses may be entitled to their own recovery for the loss of companionship and support.

Recent settlements in related fields show the scale of these cases. In October 2024, Becton Dickinson agreed to settle roughly 38,000 hernia mesh claims for an estimated $1 billion. While every case is different and there is no guarantee of outcome, these settlements prove that the legal system can force these companies to pay for the damage they cause. Attorney911’s Ralph Manginello is focused on ensuring Oklahoma survivors get their fair share of any future global settlements or individual verdicts.

Case Highlight: The Bermudez Authority Signal

Our firm is currently lead counsel in Bermudez v. Pi Kappa Phi Fraternity, Inc., et al., seeking $10,000,000 in damages for a high-profile institutional liability case. While that case involves different facts, it demonstrates the structural capability of Ralph Manginello and Lupe Peña to prosecute complex, multi-defendant litigation against national organizations. We apply that same “trial-ready” intensity to our defective medical device cases. We don’t just file papers; we build cases that are prepared for a jury. This reputation for aggressive litigation is why we maintain an Avvo 8.2 “Excellent” rating and a 4.9-star review score across hundreds of Birdeye reviews.

Frequently Asked Questions for Oklahoma Patients

We know you have questions. Here are the answers to the most common concerns we hear from Oklahoma women and their families.

1. Is surgical mesh approved by the FDA for breast surgery?

No. As of the November 9, 2023 FDA letter, the agency has stated that the safety and effectiveness of surgical mesh (including ADM and GalaFLEX) has not been determined for use in breast reconstruction or augmentation. It is entirely “off-label.”

2. Can I sue if my surgery was several years ago?

Yes, in many cases. Oklahoma’s two-year statute of limitations typically begins when you discover the link between your injury and the device. If you only recently learned your BIA-ALCL or chronic infections were caused by a defective product, you may still have a valid claim. Call Ralph Manginello at 1-888-ATTY-911 to check your specific dates.

3. How do I find out which brand of mesh was used in me?

You must request your “Operative Report” and “Implant Log” from your Oklahoma hospital or surgical center. These documents contain the implant stickers with the lot numbers and brand names (e.g., GalaFLEX, AlloMax, or Strattice). Our firm can help you obtain these records.

4. What is BIA-ALCL exactly?

It is a rare but serious T-cell lymphoma (cancer) of the immune system found in the capsule around the implant. It is highly associated with textured surface implants, like the recalled Allergan BIOCELL products.

5. What if my surgeon said the mesh was safe?

Surgeons are often the victims of manufacturer misinformation themselves. Under the “Learned Intermediary Doctrine,” manufacturers claim they only have to warn the doctor, not you. However, our firm argues that when manufacturers promote devices off-label—as BD did with GalaFLEX—they lose that protection.

6. Do I need to have the mesh removed to file a lawsuit?

While having the device removed (explanted) often provides the strongest physical evidence, you can still pursue a claim if you are currently suffering from complications or have a confirmed diagnosis like BIA-ALCL.

7. What is Red Breast Syndrome?

It is a non-bacterial inflammation specific to ADM (like AlloDerm or FlexHD). It causes the breast skin to turn red and feel warm, often being mistaken for a persistent infection. It is caused by toxins left on the tissue during the manufacturing process.

8. Is there a class action for GalaFLEX or ADM?

These are typically handled as individual lawsuits consolidated into “Multidistrict Litigation” (MDL). This allows you to have your own case while benefiting from the shared evidence gathered against the manufacturer.

9. What does it cost to hire Attorney911?

We work on a contingency fee. There is no fee unless we recover compensation for you. We are dedicated to providing Oklahoma families with elite legal representation regardless of their current financial situation.

10. Can Lupe Peña speak with my family in Spanish?

Yes. Hablamos español. Lupe Peña conducts full client consultations in fluent Spanish without the need for an interpreter. This ensures that every nuance of your medical and legal situation is understood.

11. What if I live in a rural part of Oklahoma?

We serve patients across the entire state of Oklahoma. You do not need to travel to a major office to begin your case. We can handle consultations via phone, video, and mail, and we have the resources to litigate in any federal or state court where your case belongs.

12. Who is the lawsuit filed against?

In most cases, the primary defendant is the device manufacturer (like Allergan, Becton Dickinson, or MTF Biologics). In some instances, if the surgeon or hospital in Oklahoma failed to follow FDA warnings or used a contraindicated product, they may also be named as defendants.

13. What is “Predicate Creep”?

It is the process where a device gets cleared by the FDA because it looks like an old device, which looked like an even older device. This allows materials that have never been tested in a woman’s breast to be used in surgery.

14. What are the signs of sepsis?

High fever, confusion, rapid heart rate, and severe pain at the surgical site. This is a medical emergency for any Oklahoma patient with surgical mesh. Seek immediate care, then call us.

15. How long does a lawsuit take in Oklahoma?

Medical device litigation can take several years. However, once an MDL is established, there is a predictable path for settlements. We keep our Oklahoma clients updated every step of the way.

16. What is CPT 15777?

This is the insurance billing code for ADM. A recent controversy involves Cigna declaring GalaFLEX “medically necessary” under this code, despite FDA warnings that its safety hasn’t been determined. This insurance-defense-style insight is part of the advantage Lupe Peña and Ralph Manginello bring to your case.

17. Can my family sue if my loved one died?

Yes. Oklahoma allows for “wrongful death” claims if a defective device caused a fatal infection or cancer. These claims can recover for the family’s loss and the decedent’s final expenses.

18. What makes Attorney911 different from other firms?

We are not just a “referral” firm. Ralph Manginello has twenty-seven years of continuous practice and is a member of the Pro Bono College of the State Bar of Texas. We have a documented footprint in high-stakes litigation like the Bermudez case and we know the science of mesh pathology inside and out.

19. If my implants weren’t recalled, can I still sue?

Yes. Recalls are rare and often come late. Defective design and failure to warn apply even if the FDA has not yet issued a formal recall for your specific brand of ADM or scaffold.

20. What evidence should I save?

Keep your “implant card,” any photos of your injuries or infections, and a log of your symptoms. Most importantly, do not allow the hospital to “discard” the mesh or ADM if it is removed—that material is critical evidence.

21. What if I can’t find my surgeon?

We can find them. We have investigator resources to track down medical records and surgical logs even from practices in Oklahoma that have closed or been bought out by larger healthcare systems.

22. Is there a “safe” type of mesh?

The FDA has explicitly stated that no mesh product is currently cleared for breast surgery. While some products have lower infection rates, the “off-label” risk exists for all of them.

23. What should I do right now?

If you are in pain or have been diagnosed with an injury linked to mesh, call 1-888-ATTY-911 immediately. Speak with Ralph Manginello or Lupe Peña to understand your rights before any more time passes.

24. Does the “Learned Intermediary Doctrine” apply in Oklahoma?

Yes, Oklahoma generally recognizes this doctrine. However, there are exceptions when the manufacturer provides misleading information to the doctor or engages in direct-to-consumer advertising that masks the risks.

25. Will my case go to trial?

Most mesh cases settle before trial, especially when they are part of a national MDL. However, we prepare every Oklahoma case as if it is going to trial to ensure we have the leverage to get the maximum settlement.

Oklahoma Resources for Breast Cancer and Reconstruction Survivors

If you are navigating a reconstruction failure in Oklahoma, you are not alone. Beyond legal representation, we encourage our clients to connect with independent support networks. Organizations like FORCE: Facing Our Risk of Cancer Empowered (facingourrisk.org) provide peer support for those with BRCA1/2 mutations. The Susan G. Komen Breast Care Helpline (1-877-465-6636) and the American Cancer Society (1-800-227-2345) offer assistance in both English and Spanish for Oklahoma residents.

Oklahoma is home to leading institutions like the Stephenson Cancer Center, which is an NCI-Designated Cancer Center. These institutions often have patient navigators who can help you understand your medical options for reconstruction salvage, such as autologous tissue flaps (DIEP or TRAM flaps), which use your own tissue instead of high-risk synthetic scaffolds.

A Compassionate Path Forward with Attorney911

At The Manginello Law Firm, PLLC, we see the person behind the file. We know that for our clients in Oklahoma City, Tulsa, Broken Arrow, and Lawton, this isn’t just a “mass tort”—it’s a fundamental violation of your bodily autonomy. You went into surgery expecting to be made whole, and instead, you were implanted with a device that the FDA says was never determined to be safe or effective for that use.

Ralph Manginello and Lupe Peña are ready to stand with you. Our firm’s twenty-seven years of continuous practice, our 4.9-star Birdeye rating across hundreds of reviews, and our current leadership in institutional liability cases like Bermudez v. Pi Kappa Phi prove that we have the power and the passion to fight for Oklahoma.

Si ha sido lesionada por una malla mamaria defectuosa o una matriz dérmica acelular, estamos aquí para ayudarle. Lupe Peña ofrece consultas completas en español para asegurar que usted y su familia reciban la justicia que merecen.

Contact us today at 1-888-ATTY-911 (1-888-288-9911). There is no cost for the call, no obligation to hire us, and no fee unless we win your case. Let us help you take the first step toward reclaiming your health and your dignity in Oklahoma.

The Manginello Law Firm, PLLC

1177 West Loop South, Suite 1600
Houston, Texas 77027
1-888-ATTY-911
Serving Victims Throughout Oklahoma and Nationwide

Disclaimer: This content is for educational purposes and does not constitute medical or legal advice. Past results do not guarantee future outcomes. No attorney-client relationship is formed until a written contract is signed. We are a private law firm and are not affiliated with the FDA or any government agency.